121 related articles for article (PubMed ID: 6348194)
1. Immunocytochemical localization of the functional fraction of lipoprotein lipase in the perfused heart.
Pedersen ME; Cohen M; Schotz MC
J Lipid Res; 1983 May; 24(5):512-21. PubMed ID: 6348194
[TBL] [Abstract][Full Text] [Related]
2. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
[TBL] [Abstract][Full Text] [Related]
3. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Liu L; Severson DL
Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
[TBL] [Abstract][Full Text] [Related]
6. Dual localization of lipoprotein lipase in rat heart. Its relationship to chylomicron degradation.
Stam H; Jansen H; Hülsmann WC
Adv Myocardiol; 1982; 3():509-17. PubMed ID: 7170439
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of rat heart endothelial lipoprotein lipase.
Chajek-Shaul T; Bengtsson-Olivecrona G; Peterson J; Olivecrona T
Am J Physiol; 1988 Sep; 255(3 Pt 1):E247-54. PubMed ID: 3421325
[TBL] [Abstract][Full Text] [Related]
8. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
Braun JE; Severson DL
Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
[TBL] [Abstract][Full Text] [Related]
9. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
Sambandam N; Lim F; Cam MC; Rodrigues B
J Cardiovasc Pharmacol; 1997 Jul; 30(1):110-7. PubMed ID: 9268229
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase activation of heparin-releasable lipoprotein lipase in rat heart.
Oscai LB; Caruso RA; Palmer WK
Biochem Biophys Res Commun; 1986 Feb; 135(1):196-200. PubMed ID: 3954770
[TBL] [Abstract][Full Text] [Related]
11. Rapid changes in rat heart lipoprotein lipase activity after feeding carbohydrate.
Pedersen ME; Schotz MC
J Nutr; 1980 Mar; 110(3):481-7. PubMed ID: 7359219
[TBL] [Abstract][Full Text] [Related]
12. Hormonal mediation of rat heart lipoprotein lipase activity after fat feeding.
Pedersen ME; Wolf LE; Schotz MC
Biochim Biophys Acta; 1981 Oct; 666(1):191-7. PubMed ID: 6271234
[TBL] [Abstract][Full Text] [Related]
13. Heparin-decasaccharides impair the catabolism of chylomicrons.
Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):437-44. PubMed ID: 8973550
[TBL] [Abstract][Full Text] [Related]
14. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Rodrigues B; Severson DL
Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
[TBL] [Abstract][Full Text] [Related]
15. Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma.
Kaysen GA; Pan XM; Couser WG; Staprans I
Am J Kidney Dis; 1993 Jul; 22(1):128-34. PubMed ID: 8322775
[TBL] [Abstract][Full Text] [Related]
16. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
Rodrigues B; Spooner M; Severson DL
Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
[TBL] [Abstract][Full Text] [Related]
17. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
Carroll R; Juhasz A; Severson DL
Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
[TBL] [Abstract][Full Text] [Related]
19. Comparison of heparin-releasable lipase and tissue neutral lipase activity of rat heart.
Stam H; Hülsmann WC
Biochem Int; 1983 Aug; 7(2):187-95. PubMed ID: 6679339
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
Braun JE; Severson DL
Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
